Guselkumab vs Secukinumab Treatment Outcomes in Self-Reported PsA
In the subset of patients with self-reported psoriatic arthritis, guselkumab demonstrated better maintenance of response and higher efficacy compared with secukinumab in the treatment of moderate to severe plaque psoriasis.